Skip to Main Content

Paper Details

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.
J Am Heart Assoc
0
2023
Anthracycline, Anthracycline-Induced Cardiomyopathy, CRISPR, CRISPR-associated protein 9, Cas9, Childhood Cancer, Interleukin 1 receptor type 1, 2, Peripheral Blood, altered genes, and genes, anthracycline, blood, blood-, cancer, cardiac damage, cardiac dilation, cardiomyopathy, cardiotoxicity, childhood cancer, cluster of differentiation 36, cluster of differentiation 36 (), differentially expressed genes, doxorubicin, failing heart, hepatic fibrosis, human, human-induced pluripotent stem cell-derived cardiomyocytes, iron, lactate, lactate dehydrogenase A, mRNA, matrix metalloproteinase 8, 9, matrix metalloproteinases, myocardial infarction, peripheral blood, premature death, total RNA
Author NameAffiliation
Douglas S HawkinsDepartment of Pediatrics Seattle Children's Hospital WA Seattle.
Melissa M HudsonDepartment of Epidemiology and Cancer Control St. Jude Children's Research Hospital Memphis TN.
Joseph P NegliaDepartment of Pediatrics University of Minnesota Minneapolis MN.
Joseph P NegliaDepartment of Pediatrics University of Minnesota Minneapolis MN.
Jill P GinsbergDepartment of Pediatrics Children's Hospital of Philadelphia Philadelphia PA.
Smita BhatiaInstitute for Cancer Outcomes and Survivorship University of Alabama at Birmingham Birmingham AL.
Smita BhatiaDepartment of Pediatrics University of Alabama at Birmingham Birmingham AL.
Smita BhatiaInstitute for Cancer Outcomes and Survivorship University of Alabama at Birmingham Birmingham AL.
Smita BhatiaDepartment of Pediatrics University of Alabama at Birmingham Birmingham AL.
  • 1 - 9

Datasets

Release 1.2